Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Assessing the effect of excipients on the ability to attain and maintain supersaturation of drug-based solution may provide useful information for the design of solid formulations. Judicious selection of materials that affect either the extent or stability of supersaturating drug delivery systems may be enabling for poorly soluble drug candidates or other difficult-to-formulate compounds. The technique suggested herein is aimed at providing a screening protocol to allow preliminary assessment of these factors based on small to moderate amounts of drug substance. A series of excipients were selected that may, by various mechanisms, affect supersaturation including pharmaceutical polymers such as HMPC and PVP, surfactants such as Polysorbate 20, Cremophor RH40 and TPGS and hydrophilic cyclodextrins such as HPbetaCD. Using a co-solvent based method and 25 drug candidates, the data suggested, on the whole, that the surfactants and the selected cyclodextrin seemed to best augment the extent of supersaturation but had variable benefits as stabilizers, while the pharmaceutical polymers had useful effect on supersaturation stability but were less helpful in increasing the extent of supersaturation. Using these data, a group of simple solid dosage forms were prepared and tested in the dog for one of the drug candidates. Excipients that gave the best extent and stability for the formed supersaturated solution in the screening assay also gave the highest oral bioavailability in the dog.
Vandecruys
Roger
R
Pharmaceutical Development, Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium.
Peeters
Jef
J
Verreck
Geert
G
Brewster
Marcus E
ME
D000042:Absorption; D000818:Animals; D019540:Area Under Curve; D001682:Biological Availability; D002214:Capsules; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D003460:Crystallization; D004058:Diffusion; D004285:Dogs; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry*; D007202:Indicators and Reagents; D013058:Mass Spectrometry; D019999:Pharmaceutical Solutions / Q000737:chemistry*; D012212:Rheology; D012997:Solvents; D013500:Surface Tension; D013607:Tablets
D002214:Capsules; D005079:Excipients; D007202:Indicators and Reagents; D019999:Pharmaceutical Solutions; D012997:Solvents; D013607:Tablets